New Drug Applications FDA Issues a Complete Response Letter for New Drug Application for Dasotraline for the Treatment of ADHD 6 years ago
Pharma Industry News Testing Topicals: Analytical Strategies for the In-Vitro Demonstration of Bioequivalence 6 years ago